Pillar® oncoReveal™ Multi-Cancer CNV + RNA Fusion Panel

The oncoReveal™ Multi-Cancer with CNV and RNA Fusion Panel is a combined DNA/RNA multi-cancer panel. The assay combines the DNA-based ONCO/Reveal Multi-Cancer v4 with CNV Panel with the ONCO/Reveal Multi-Cancer RNA Fusion v2 Panel allowing for joint sequencing. The assay uses proprietary Stem Loop Inhibition-Mediated amplification (SLIMamp®) technology, a tiled amplicon-based library prep chemistry for efficient single-tube target enrichment.

• Maintain control of samples and results with single-tube, tiled amplification that can be performed in-house by any NGS lab
• Achieve variant detection as low as 1% VAF without UIDs, even with limited DNA input or poor sample quality
• Improve lab efficiency and reduce “no calls”, repeat testing and difficult interpretation decisions
• < 8 hours DNA to sequencer, <9-10 hours RNA to sequencer